DE3265852D1 - 3-beta,7-beta,15-alpha-trihydroxy-5-androsten-17-one, its 3,15-dipivalate, and its preparation - Google Patents

3-beta,7-beta,15-alpha-trihydroxy-5-androsten-17-one, its 3,15-dipivalate, and its preparation

Info

Publication number
DE3265852D1
DE3265852D1 DE8282108252T DE3265852T DE3265852D1 DE 3265852 D1 DE3265852 D1 DE 3265852D1 DE 8282108252 T DE8282108252 T DE 8282108252T DE 3265852 T DE3265852 T DE 3265852T DE 3265852 D1 DE3265852 D1 DE 3265852D1
Authority
DE
Germany
Prior art keywords
beta
alpha
androsten
trihydroxy
dipivalate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8282108252T
Other languages
German (de)
English (en)
Inventor
Karl Dr Petzoldt
Henry Dr Laurent
Rudolf Prof Dr Wiechert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Priority to DE8282108252T priority Critical patent/DE3265852D1/de
Application granted granted Critical
Publication of DE3265852D1 publication Critical patent/DE3265852D1/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00—Preparation of steroids
    • C12P33/12—Acting on D ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C07J53/004—3 membered carbocyclic rings
    • C07J53/008—3 membered carbocyclic rings in position 15/16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00—Preparation of steroids
    • C12P33/06—Hydroxylating

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE8282108252T 1981-09-21 1982-09-08 3-beta,7-beta,15-alpha-trihydroxy-5-androsten-17-one, its 3,15-dipivalate, and its preparation Expired DE3265852D1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE8282108252T DE3265852D1 (en) 1981-09-21 1982-09-08 3-beta,7-beta,15-alpha-trihydroxy-5-androsten-17-one, its 3,15-dipivalate, and its preparation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3137919 1981-09-21
DE8282108252T DE3265852D1 (en) 1981-09-21 1982-09-08 3-beta,7-beta,15-alpha-trihydroxy-5-androsten-17-one, its 3,15-dipivalate, and its preparation

Publications (1)

Publication Number Publication Date
DE3265852D1 true DE3265852D1 (en) 1985-10-03

Family

ID=6142442

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8282108252T Expired DE3265852D1 (en) 1981-09-21 1982-09-08 3-beta,7-beta,15-alpha-trihydroxy-5-androsten-17-one, its 3,15-dipivalate, and its preparation

Country Status (11)

Country Link
US (1) US4435327A (US07816562-20101019-C00012.png)
EP (1) EP0075189B1 (US07816562-20101019-C00012.png)
JP (1) JPS5865299A (US07816562-20101019-C00012.png)
AT (1) ATE15206T1 (US07816562-20101019-C00012.png)
AU (1) AU555388B2 (US07816562-20101019-C00012.png)
CA (1) CA1203796A (US07816562-20101019-C00012.png)
DE (1) DE3265852D1 (US07816562-20101019-C00012.png)
DK (1) DK411882A (US07816562-20101019-C00012.png)
HU (1) HU185184B (US07816562-20101019-C00012.png)
IE (1) IE53956B1 (US07816562-20101019-C00012.png)
IL (1) IL66820A (US07816562-20101019-C00012.png)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3042136A1 (de) * 1980-11-03 1982-06-09 Schering Ag, 1000 Berlin Und 4619 Bergkamen Verfahren zur herstellung von 3 (beta), 7 (beta) -dihydroxy- (delta) (pfeil hoch)5(pfeil hoch) -steroiden
US5461042A (en) * 1988-12-30 1995-10-24 Loria; Roger M. Regulation of the immune system
DE19633685C1 (de) 1996-08-12 1997-10-09 Schering Ag Verfahren zur Herstellung von Drospirenon (6beta,7beta;15 beta,16beta-Dimethyl-en-3-oxo-17alpha-pregn-4-en-21,17-carbolacton, DRSP) sowie 7alpha-(3-Hydroxy-1-propyl)-6beta,7beta;15beta, 16beta-dimethylen-5beta-androstan-3beta,5,17beta-triol (ZK 92836) und 6beta,7beta;15beta,16beta-dimethylen-5beta-hydroxy-3-oxo-17alpha-androstan-21,17-carbolacton (90965) als Zwischenprodukte des Verfahrens
US20050101581A1 (en) * 2002-08-28 2005-05-12 Reading Christopher L. Therapeutic treatment methods 2
WO2004070048A1 (en) * 2003-02-07 2004-08-19 Pharmacia & Upjohn Company Llc A microbial process to prepare 5-androsten-3beta, 7alpha, 15alpha-triol-17-one and related analogues
ITMI20040367A1 (it) 2004-03-01 2004-06-01 Ind Chimica Srl Processo per la preparazione di drospirenone
HUP0402466A2 (en) * 2004-11-30 2006-07-28 Richter Gedeon Vegyeszet Industrial process for preparing 17-hydroxy-6-betha, 7-betha, 15-betha, 16-betha-bis-methylene-3-oxo-17-alpha-pregn-4-ene-21-carboxylic acid gamma lacton and the main, intermediates of the process
HUP0402465A2 (en) * 2004-11-30 2006-07-28 Richter Gedeon Vegyeszet Industrial process for preparing 17-hydroxy-6-betha, 7-betha, 15-betha, 16-betha-bis-methylene-3-oxo-17-alpha-pregn-4-ene-21-carboxylic acid gamma lacton and the main intermediates of the process
DE102004058300B4 (de) 2004-12-02 2016-09-15 Austriamicrosystems Ag Schaltungsanordnung zur Erzeugung eines komplexen Signals und Verwendung in einem Hochfrequenz-Sender oder -Empfänger
ITMI20042338A1 (it) * 2004-12-06 2005-03-06 Ind Chimica Srl Processo per la preparazione di drospirenone
DK1746101T4 (da) 2005-07-21 2014-08-11 Bayer Pharma AG Fremgangsmåde til fremstilling af 3-oxo-pregn-4-en-21,17-carbolactoner ved metalfri oxidation af 17-(3-hydroxypropyl)-3,17-dihydroxyandrostaner
MX2008000936A (es) 2005-07-21 2008-03-27 Bayer Schering Pharma Ag Proceso para producir 3-oxo-pregn-4-eno-21,17-carbolactonas por oxidacion libre de metales de 17-(3-hidroxipropil)-3,17-dihidroxia ndrostanos.
US7319154B2 (en) 2005-07-21 2008-01-15 Bayer Schering Pharma Ag Process for the production of 3-oxo-pregn-4-ene-21, 17-carbolactones by the metal free oxidation of 17-(3-hydroxypropyl)-3, 17-dihydroxyandrostanes
WO2008137050A2 (en) * 2007-05-01 2008-11-13 Sicor Inc. A process for preparing drospirenone and intermediate thereof
DE102007030596B3 (de) 2007-06-28 2009-03-12 Bayer Schering Pharma Aktiengesellschaft Verfahren zur Herstellung von 17-(3-Hydroxypropyl)-17-hydroxysteroiden
CN101343306B (zh) * 2007-07-12 2011-06-08 江苏希迪制药有限公司 合成6,7-亚甲基甾体化合物的方法
US7960368B2 (en) * 2008-03-05 2011-06-14 Everstra, Inc. Bismethylene-17A carbolactones and related uses
CN101570775B (zh) * 2008-05-04 2012-03-21 上海医药工业研究院 微生物转化法制备3β,7β-二羟基-15β,16β-亚甲基-5-雄烯-17-酮的方法
WO2010068500A2 (en) * 2008-11-25 2010-06-17 Evestra, Inc. PROGESTATIONAL 3-(6,6-ETHYLENE-17b-HYDROXY-3-OXO-17a-PREGNA-4-ENE-17a -YL) PROPIONIC ACID g-LACTONES
ES2432063T3 (es) 2009-06-16 2013-11-29 Crystal Pharma, S.A.U. Procedimiento para la obtención de 17-espirolactonas en esteroides
WO2011113196A1 (zh) 2010-03-16 2011-09-22 台州太法药业有限公司 屈螺酮制备方法
EP2415778B1 (en) 2010-08-03 2013-05-15 Newchem S.p.A. Methods for the preparation of Drospirenone and intermediates thereof
ITMI20111383A1 (it) 2011-07-25 2013-01-26 Ind Chimica Srl Processo per la preparazione di drospirenone
WO2013076118A1 (en) 2011-11-22 2013-05-30 Industriale Chimica S.R.L. Process for the preparation of drospirenone
EP2597101A1 (en) 2011-11-22 2013-05-29 Industriale Chimica S.R.L. Process for the preparation of drospirenone
CN102617685B (zh) * 2012-03-08 2014-01-22 广州市赛普特医药科技有限公司 雄甾-3β,5α,6β-三醇的晶型化合物及其制备方法
CN102887934B (zh) * 2012-09-20 2015-05-27 杭州福斯特药业有限公司 一种屈螺酮的制备方法
US9695213B2 (en) 2013-02-20 2017-07-04 Industriale Chimica S.R.L. Process for the preparation of drospirenone
BR112015025816B1 (pt) 2013-04-12 2021-02-02 Industriale Chimica S.R.L processo para a preparação de drospirenona
CN104163846A (zh) * 2013-05-17 2014-11-26 上海创诺制药有限公司 一种制备曲螺酮的方法
CN103408628B (zh) * 2013-08-19 2015-12-02 江苏佳尔科药业集团有限公司 3β,5-二羟基-6β,7β；15β,16β-二亚甲基-5β-雄甾-17-酮的制备方法
CN110407905B (zh) * 2019-08-22 2021-09-28 武汉九珑人福药业有限责任公司 一种屈螺酮及其中间体的制备方法
CN114478672B (zh) * 2022-01-27 2024-06-14 浙江仙居君业药业有限公司 一种he3286的合成方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2652761C2 (de) * 1976-11-16 1985-11-21 Schering AG, 1000 Berlin und 4709 Bergkamen 15,16-Methylen-Spirolactone, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE2746298A1 (de) * 1977-10-13 1979-04-19 Schering Ag 4-androsten-3,17-dion-derivate, ihre herstellung und verwendung
US4303754A (en) * 1980-03-17 1981-12-01 Macdonald Ian Method for obtaining 7β hydroxy steroids
DE3042136A1 (de) * 1980-11-03 1982-06-09 Schering Ag, 1000 Berlin Und 4619 Bergkamen Verfahren zur herstellung von 3 (beta), 7 (beta) -dihydroxy- (delta) (pfeil hoch)5(pfeil hoch) -steroiden

Also Published As

Publication number Publication date
EP0075189B1 (en) 1985-08-28
IE53956B1 (en) 1989-04-26
IL66820A0 (en) 1982-12-31
IL66820A (en) 1985-12-31
IE822284L (en) 1983-03-21
ATE15206T1 (de) 1985-09-15
DK411882A (da) 1983-03-22
US4435327A (en) 1984-03-06
HU185184B (en) 1984-12-28
AU8845882A (en) 1983-03-31
JPS5865299A (ja) 1983-04-18
EP0075189A1 (en) 1983-03-30
JPH0357917B2 (US07816562-20101019-C00012.png) 1991-09-03
CA1203796A (en) 1986-04-29
AU555388B2 (en) 1986-09-25

Similar Documents

Publication Publication Date Title
DE3265852D1 (en) 3-beta,7-beta,15-alpha-trihydroxy-5-androsten-17-one, its 3,15-dipivalate, and its preparation
AU7120191A (en) Method for making an apparatus for treatment of hypertrophy of the prostate gland
ZA796548B (en) Polysaccharide s-60 and bacterial fermentation process for its preparation
NL191308C (nl) Gelyofiliseerd, na oplossing injecteerbaar preparaat dat een antracycline-glycoside bevat, alsmede werkwijze voor de bereiding van een injecteerbare oplossing van een antracycline-glycoside.
AU5406279A (en) Absorption process and apparatus
HU902775D0 (en) Acid-resisting preparations especially for sulphate-concrete tubes and process for its production
GB2100601B (en) An aromatase-inhibitor for use in a method of prophylaxis and/or of treatment by therapy of prostatic hyperplasia, and pharmaceutical preparations suitable for such a use.
AU5038379A (en) Chromatography process and apparatus
AU8226387A (en) A process for the preparation of an organ-specific substance labeled with technetium-99m
GB2071160B (en) Method and aparatus for the metallization of fibres
AU4542379A (en) Chromatographic apparatus and method
JPS553399A (en) Glass panel and its manufacturing method and apparatus
YU283080A (en) Process for obtaining binding agents on the base of epoxyester resins completely or partially neutralized by means of inorganic and or organic acids
EP0315539A3 (fr) Esters aromatiques polycycliques d'antibiotiques macrolidiques et lincosamidiques, leur procédé de préparation et compositions pharmaceutiques et cosmétiques les contenant
HU179689B (en) Pharmaceutical composition against psoriasis and process for preparing such composition
IS1697B (is) Hliðstæð aðferð til framleiðslu á 3,3'-dithiobis (própíónsýrum) og esterum þeirra
AU523580B2 (en) Methods and apparatus for preheating glass batch pellets
DE2963189D1 (en) 9-alpha-hydroxy-3-oxopregna-4,17(20)-diene-20-carboxylic acid and its methyl ester and methods for the microbiological production thereof
JPS5220099A (en) Automatic ticket examination method
EP0315536A3 (fr) Esters polyaromatiques d'antibiotiques macrolidiques et lincosamidiques, leur procédé de préparation et compositions pharmaceutiques et cosmétiques les contenant
GB2012267A (en) Aminoglycoside antibiotics and process for producion thereof
DE69020627D1 (de) Supraleitende Einrichtung mit drei Anschlüssen und Prozess für deren Herstellung.
GB2033902B (en) 1,6-naphthyridine derivatives process for the production thereof and pharmaceutical composition containing such derivatives
AU7160887A (en) Antiparatypical antibodies, their use for detecting and treating auto-immune diseases
DE2964718D1 (en) Process for the preparation of 7-oxabicyclo(4.1.0)heptane-3,4-dicarboxylic acid diglycidyl ester

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: SCHERING AG, 13353 BERLIN, DE